Medicosnext

Antimicrobial resistance (AMR) is a global public health threat, and there is an ever growing list of bacteria that are becoming resistant to treatment with the currently available antibiotics. To add to this, very few new antibiotics are in the pipeline. Now, researchers at the Wistar Institute, USA, say that …

An Iowa State University research study published in the November 2020 issue of Journal of Alzheimer’s Disease has concluded that the foods we eat may directly impact our future cognitive acuity. Headed by Auriel Willette, an assistant professor in Food Science and Human Nutrition, and Brandon Klinedinst, a Neuroscience PhD …

New research says that those who spend too much time on social media are apt to be depressed later on. Of course, the issue could be seen from another angle, depressed people may spend more time online, shying away from face-to-face interactions. Dr. Brian Primack, a professor of public health …

Dr. Sudha Sharma, MBBS, DGO, FRCOG, MPH, former Secretary of the Ministry of Health and Population, Nepal, is an obstetrician gynecologist and public health expert with major experiences in policy, governance, health systems, and quality of healthcare. She is a Fellow of the Royal College of Obstetricians and Gynecologists, UK, …

  It is said that ‘the status of any state is reflected by its healthcare status’. At the very first glance, this sentence seems confusing and non-convincing. However, if we concentrate on the feeling encrypted in this statement for some more time, we gradually land on reality. We have been …

Roche’s Phesgo (pertuzumab/trastuzumab) is one of the half dozen medicines that the European Medicines Agency’s human medicines committee (CHMP) has recommended for approval at its November 2020 meeting. Phesgo has been endorsed as a treatment for early and metastatic breast cancer. Administered as a subcutaneous, fixed-dose combination of pertuzumab and …

The ongoing World Health Organization (WHO) Solidarity Trial of hydroxychloroquine, remdesivir, lopinavir, or interferon-beta-1a for the treatment of COVID-19 were found not to prevent in-hospital death, reduce need for ventilation, or shorten duration of hospitalization. The results have been published in the New England Journal of Medicine. The open-label study …

Researchers at the Institute for Biomedical Sciences, Georgia State University, have discovered that a new antiviral drug, Molnupiravir (MK-4482/EIDD-2801), completely suppresses SARS-CoV-2 transmission within 24 hours. The drug was originally found to be potent against influenza viruses. According to research team leader Dr. Richard Plemper, it is the first orally …

A recent study has demonstrated that an experimental drug named ISRIB (integrated stress response inhibitor) rapidly restored youthful cognitive abilities in aged mice. The researchers said that ISRIB’s extremely rapid effects showed that an important component of age-related cognitive loss could be caused by reversible physiological “blockage”, rather than more …

  In what is a major leap forward in the advancement of regenerative therapy, scientists at Sanford Burnham Prebys Medical Discovery Institute, California, have created a drug that can lure stem cells to damaged tissue and improve treatment efficacy. The ability to instruct a stem cell to go to a …